ATE546434T1 - Chinolonderivat bzw. pharmazeutisch zulässiges salz daraus - Google Patents
Chinolonderivat bzw. pharmazeutisch zulässiges salz darausInfo
- Publication number
- ATE546434T1 ATE546434T1 AT07738511T AT07738511T ATE546434T1 AT E546434 T1 ATE546434 T1 AT E546434T1 AT 07738511 T AT07738511 T AT 07738511T AT 07738511 T AT07738511 T AT 07738511T AT E546434 T1 ATE546434 T1 AT E546434T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitory activity
- platelet aggregation
- lower alkylene
- quinolone derivatives
- quinolone derivative
- Prior art date
Links
- 150000007660 quinolones Chemical class 0.000 title abstract 4
- 150000003839 salts Chemical class 0.000 title abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 229940127218 antiplatelet drug Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006073045 | 2006-03-16 | ||
PCT/JP2007/055040 WO2007105751A1 (ja) | 2006-03-16 | 2007-03-14 | キノロン誘導体又はその製薬学的に許容される塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE546434T1 true ATE546434T1 (de) | 2012-03-15 |
Family
ID=38509567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07738511T ATE546434T1 (de) | 2006-03-16 | 2007-03-14 | Chinolonderivat bzw. pharmazeutisch zulässiges salz daraus |
Country Status (17)
Country | Link |
---|---|
US (2) | US8133882B2 (de) |
EP (1) | EP1995240B1 (de) |
JP (1) | JP5169821B2 (de) |
KR (1) | KR20080110818A (de) |
CN (1) | CN101400655B (de) |
AT (1) | ATE546434T1 (de) |
AU (1) | AU2007225678B2 (de) |
BR (1) | BRPI0709608A2 (de) |
CA (1) | CA2645711A1 (de) |
DK (1) | DK1995240T3 (de) |
ES (1) | ES2380246T3 (de) |
MX (1) | MX2008011721A (de) |
NO (1) | NO20084319L (de) |
RU (1) | RU2440987C2 (de) |
TW (1) | TWI391378B (de) |
WO (1) | WO2007105751A1 (de) |
ZA (1) | ZA200807904B (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI391378B (zh) * | 2006-03-16 | 2013-04-01 | Astellas Pharma Inc | 喹啉酮衍生物或其製藥學上可被容許之鹽 |
JPWO2008133155A1 (ja) | 2007-04-19 | 2010-07-22 | アステラス製薬株式会社 | 二環式ヘテロ環化合物 |
BRPI0915350A2 (pt) * | 2008-06-13 | 2016-05-03 | Bayer Cropscience Ag | novas amidas e tioamidas heteroatômicas como pesticidas |
CN102405220B (zh) * | 2009-04-22 | 2015-05-27 | 埃科特莱茵药品有限公司 | 噻唑衍生物及其作为p2y12受体拮抗剂的用途 |
US8729095B2 (en) | 2009-08-28 | 2014-05-20 | Daiichi Sankyo Company, Limited | 3-(biaryloxy)propionic acid derivatives for prevention and/or treatment of thromboembolic diseases |
UA112418C2 (uk) | 2010-09-07 | 2016-09-12 | Астеллас Фарма Інк. | Терапевтичний болезаспокійливий засіб |
WO2012174013A2 (en) * | 2011-06-14 | 2012-12-20 | Cardeus Pharmaceuticals, Inc. | Treatment of cardiovascular disease, stroke, and inflammatory conditions |
CN102320981B (zh) * | 2011-07-19 | 2014-12-31 | 上海泰坦化学有限公司 | 手性中间体(s)-1-环丁基乙胺盐酸盐的制备方法 |
WO2013033178A1 (en) | 2011-08-30 | 2013-03-07 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
AU2013361060B2 (en) * | 2012-12-21 | 2018-04-19 | Epizyme, Inc. | 1,4-pyridone compounds |
WO2014100665A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | 1,4-pyridone bicyclic heteroaryl compounds |
KR102594117B1 (ko) | 2014-10-01 | 2023-10-26 | 메디뮨 리미티드 | 티카그렐로에 대한 항체 및 이의 사용 방법 |
US9382208B1 (en) | 2015-01-26 | 2016-07-05 | Vanderbilt University | Negative allosteric modulators of metabotropic glutamate receptor 2 |
ES2881228T3 (es) | 2015-02-16 | 2021-11-29 | Univ Queensland | Sulfonilureas y compuestos relacionados y uso de los mismos |
CN104844590B (zh) * | 2015-03-30 | 2017-07-28 | 河南大学 | 一种n‑甲基环丙沙星(绕丹宁不饱和酮)酰胺类衍生物及其制备方法和应用 |
CN106317047B (zh) * | 2015-06-15 | 2019-01-11 | 河南大学 | 一种n-甲基加替沙星(绕丹宁不饱和酮)酰胺类衍生物及其制备方法和应用 |
CN106317046B (zh) * | 2015-06-15 | 2019-04-23 | 河南大学 | 一种培氟沙星(绕丹宁不饱和酮)酰胺类衍生物及其制备方法和应用 |
CN106317045B (zh) * | 2015-06-15 | 2019-04-23 | 河南大学 | 一种氟罗沙星(绕丹宁不饱和酮)酰胺类衍生物及其制备方法和应用 |
CN106317048B (zh) * | 2015-06-15 | 2019-01-11 | 河南大学 | 一种n-甲基洛美沙星(绕丹宁不饱和酮)酰胺类衍生物及其制备方法和应用 |
CN106279019B (zh) * | 2015-06-26 | 2018-11-09 | 河南大学 | 一种恩诺沙星的α,β-不饱和酮衍生物及其制备方法和应用 |
CN106316947B (zh) * | 2015-06-26 | 2018-11-09 | 河南大学 | 一种诺氟沙星的α,β-不饱和酮衍生物及其制备方法和应用 |
CN108884049A (zh) * | 2016-02-09 | 2018-11-23 | 法玛克亚公司 | 喹啉酮赖氨酰氧化酶样2抑制剂及其用途 |
EP3541431B1 (de) * | 2016-11-16 | 2024-04-17 | The General Hospital Corporation | Myeloperoxidasekontrastmittel |
US11465992B2 (en) | 2017-07-07 | 2022-10-11 | Inflazome Limited | Sulfonamide carboxamide compounds |
EP3668843A1 (de) | 2017-08-15 | 2020-06-24 | Inflazome Limited | Sulfonylharnstoffe und sulfonylthioharnstoffe als nlrp3-inhibitoren |
US11518739B2 (en) | 2017-08-15 | 2022-12-06 | Inflazome Limited | Sulfonamide carboxamide compounds |
BR112020003014A2 (pt) | 2017-08-15 | 2020-07-28 | Inflazome Limited | sulfonilureias e sulfoniltioureias como inibidores de vnlrp3 |
WO2019034692A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3 |
EP3759077A1 (de) | 2018-03-02 | 2021-01-06 | Inflazome Limited | Neuartige verbindungen |
EP3915563A1 (de) | 2020-05-27 | 2021-12-01 | Administración General de la Comunidad Autónoma de Euskadi | Foxo-inhibitoren zur verwendung bei der behandlung von krankheiten, die durch abnormale verarbeitung von tdp-43- und/oder fus-proteinen verursacht werden |
CN114133387B (zh) * | 2021-11-29 | 2023-04-07 | 郑州大学 | 具有粘度传感性质的可靶向多种细胞器的荧光探针 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5466290A (en) | 1990-11-05 | 1995-11-14 | Mcneil-Ppc, Inc. | Drying systems for apparatus for gelatin coating tablets |
JPH06316522A (ja) * | 1993-03-09 | 1994-11-15 | Takeda Chem Ind Ltd | 細胞接着阻害剤 |
TW301607B (de) | 1993-03-09 | 1997-04-01 | Takeda Pharm Industry Co Ltd | |
KR100516379B1 (ko) | 1996-11-28 | 2005-09-26 | 와쿠나가 세이야쿠 가부시키 가이샤 | 신규 피리돈카르복실산 유도체 또는 그의 염 및 이를 유효 성분으로 하는 의약 |
TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
JP3519078B2 (ja) | 2000-11-01 | 2004-04-12 | 山之内製薬株式会社 | 抗血小板剤スクリーニング方法 |
US6861424B2 (en) | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
WO2003022214A2 (en) | 2001-09-06 | 2003-03-20 | Millennium Pharmaceuticals, Inc. | Piperazine and homopiperazine compounds |
WO2005002574A1 (en) | 2003-06-24 | 2005-01-13 | Actelion Pharmaceuticals Ltd | Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
DE20311149U1 (de) * | 2003-07-18 | 2003-10-16 | Schneider Engineering Gmbh | Tankmulde aus Kunststoff |
JP4725047B2 (ja) * | 2003-07-24 | 2011-07-13 | アステラス製薬株式会社 | キノロン誘導体又はその塩 |
EP1650192A4 (de) | 2003-07-24 | 2007-03-21 | Astellas Pharma Inc | Chinolonderivat oder salz davon |
MXPA06003625A (es) | 2003-10-03 | 2006-08-11 | Portola Pharm Inc | Isoquinolinonas sustituidas. |
JP2008094720A (ja) | 2005-01-20 | 2008-04-24 | Astellas Pharma Inc | キノロン誘導体のプロドラッグ又はその塩 |
TWI391378B (zh) * | 2006-03-16 | 2013-04-01 | Astellas Pharma Inc | 喹啉酮衍生物或其製藥學上可被容許之鹽 |
-
2007
- 2007-03-13 TW TW096108642A patent/TWI391378B/zh not_active IP Right Cessation
- 2007-03-14 ES ES07738511T patent/ES2380246T3/es active Active
- 2007-03-14 US US12/293,055 patent/US8133882B2/en not_active Expired - Fee Related
- 2007-03-14 AU AU2007225678A patent/AU2007225678B2/en not_active Ceased
- 2007-03-14 CN CN200780009148XA patent/CN101400655B/zh not_active Expired - Fee Related
- 2007-03-14 JP JP2008505178A patent/JP5169821B2/ja not_active Expired - Fee Related
- 2007-03-14 ZA ZA200807904A patent/ZA200807904B/xx unknown
- 2007-03-14 RU RU2008140946/04A patent/RU2440987C2/ru not_active IP Right Cessation
- 2007-03-14 WO PCT/JP2007/055040 patent/WO2007105751A1/ja active Application Filing
- 2007-03-14 DK DK07738511.0T patent/DK1995240T3/da active
- 2007-03-14 AT AT07738511T patent/ATE546434T1/de active
- 2007-03-14 EP EP07738511A patent/EP1995240B1/de not_active Not-in-force
- 2007-03-14 MX MX2008011721A patent/MX2008011721A/es active IP Right Grant
- 2007-03-14 BR BRPI0709608-9A patent/BRPI0709608A2/pt not_active IP Right Cessation
- 2007-03-14 KR KR1020087025134A patent/KR20080110818A/ko not_active Application Discontinuation
- 2007-03-14 CA CA002645711A patent/CA2645711A1/en not_active Abandoned
-
2008
- 2008-10-15 NO NO20084319A patent/NO20084319L/no not_active Application Discontinuation
-
2012
- 2012-02-02 US US13/364,815 patent/US8629126B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2007105751A1 (ja) | 2007-09-20 |
RU2008140946A (ru) | 2010-04-27 |
CN101400655A (zh) | 2009-04-01 |
CN101400655B (zh) | 2013-01-09 |
US8133882B2 (en) | 2012-03-13 |
TW200812969A (en) | 2008-03-16 |
AU2007225678B2 (en) | 2011-11-24 |
AU2007225678A1 (en) | 2007-09-20 |
RU2440987C2 (ru) | 2012-01-27 |
ES2380246T3 (es) | 2012-05-09 |
JP5169821B2 (ja) | 2013-03-27 |
EP1995240A4 (de) | 2009-12-09 |
CA2645711A1 (en) | 2007-09-20 |
MX2008011721A (es) | 2008-11-14 |
BRPI0709608A2 (pt) | 2011-07-19 |
US8629126B2 (en) | 2014-01-14 |
KR20080110818A (ko) | 2008-12-19 |
TWI391378B (zh) | 2013-04-01 |
US20120136025A1 (en) | 2012-05-31 |
EP1995240A1 (de) | 2008-11-26 |
DK1995240T3 (da) | 2012-03-26 |
NO20084319L (no) | 2008-12-12 |
US20090197834A1 (en) | 2009-08-06 |
JPWO2007105751A1 (ja) | 2009-07-30 |
EP1995240B1 (de) | 2012-02-22 |
ZA200807904B (en) | 2009-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE546434T1 (de) | Chinolonderivat bzw. pharmazeutisch zulässiges salz daraus | |
WO2006049835A3 (en) | Indole and benzimidazole derivatives | |
TW200833686A (en) | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors | |
MY148583A (en) | Pyridine [3,4-b] pyrazinones | |
ATE495176T1 (de) | Spiroindolinon-derivate | |
MX2009012595A (es) | Derivados de espiroindolinona. | |
TW200612958A (en) | Substituted imidazole derivatives | |
MX2010006107A (es) | Derivados de espiroindolinona. | |
NZ712378A (en) | Synthetic methods for spiro-oxindole compounds | |
WO2009115562A3 (en) | Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts | |
WO2006127926A3 (en) | Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts | |
RS50670B (sr) | Supstitucionisani derivati hinolina kao mitotički kinezinski inhibitori | |
MX2013004407A (es) | Derivado de piridina y agente medicinal. | |
MY195209A (en) | Partially Saturated Nitrogen-Containing Heterocyclic Compound | |
WO2008086122A3 (en) | Imidazole derivatives as kinesin spindle protein inhibitors (eg-5) | |
WO2009023539A3 (en) | Tetrahydropyridine carboxamide derivatives as trpvl antagonists | |
MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
AR068115A1 (es) | Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida | |
DK2252611T3 (da) | (Dihydro)pyrrolo[2,1-a]isoquinoliner | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
IL186777A0 (en) | (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor | |
EP2581372A4 (de) | Cyanochinolinderivate | |
NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
WO2010149598A3 (en) | Heterocyclic antiviral compound |